Berberine as a Phytochemical in Metabolic Syndrome Management: Mechanistic Insights and Clinical Evidence
medtigo Journal of Pharmacology · 19.05.2026 · 3 (2)
DOI: 10.63096/medtigo3061322 ↗Kurz gefasst
Fachartikel in der Zeitschrift medtigo Journal of Pharmacology, online erschienen am 19.05.2026. Verfasst von Armaghan Muneer und 7 weiteren Autor:innen. Die Arbeit nennt 75 Literaturangaben.
Abstract (Originalsprache)
Background
Metabolic syndrome (MetS), which involves insulin resistance, high blood pressure, dyslipidemia, and central obesity, is a well-known risk factor for type 2 diabetes and heart disease. Growing research on natural products led to the discovery that berberine, a compound isolated from the genus Berberis, influences the regulation of metabolism.
Objective
This narrative review attempts to give an in-depth perspective on the pharmacology, therapeutic value, and application of berberine in MetS. Methdology: A thorough search of relevant scientific databases has been performed, and only those articles that address the mechanism of action and therapeutic efficacy of berberine in MetS have been considered.
Results
The mechanism of action of berberine is multifaceted, mainly via stimulation of adenosine monophosphate-activated protein kinase (AMPK), which results in better glucose utilization, increased insulin resistance, and lipid regulation. Based on clinical evidence, there have been observed changes in lowering fasting plasma glucose levels, favourable effects on lipid parameters, and a reduction in body mass index (BMI). In some instances, the drug is as effective as established drugs like metformin and statins. However, its use in medicine is hindered by poor oral absorption. Innovative approaches, such as nanotechnology, may help in maximizing its clinical benefits.
Conclusion
Berberine offers great potential for use as an adjuvant therapy in the treatment of MetS owing to its multitarget approach and relatively safe nature. However, more studies need to be done, especially in relation to better formulation approaches and clinical effects.
Zitieren
APA
Muneer, A., Noor, M., Jamshed, S., Shahid, A., Anjum, A., Parveen, F., Rahman, A., & Ali, P. A. (2026). Berberine as a Phytochemical in Metabolic Syndrome Management: Mechanistic Insights and Clinical Evidence. medtigo Journal of Pharmacology, 3(2). https://doi.org/10.63096/medtigo3061322
Vancouver
Muneer A, Noor M, Jamshed S, Shahid A, Anjum A, Parveen F, et al. Berberine as a Phytochemical in Metabolic Syndrome Management: Mechanistic Insights and Clinical Evidence. medtigo Journal of Pharmacology. 2026;3(2). doi:10.63096/medtigo3061322
BibTeX
@article{Muneer2026,
author = {Muneer, Armaghan and Noor, Maida and Jamshed, Smavia and Shahid, Amna and Anjum, Aneesa and Parveen, Fareeha and Rahman, Abdul and Ali, Pir Asif},
title = {Berberine as a Phytochemical in Metabolic Syndrome Management: Mechanistic Insights and Clinical Evidence},
journal = {medtigo Journal of Pharmacology},
year = {2026},
volume = {3},
number = {2},
doi = {10.63096/medtigo3061322}
}
EUVIMED